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Interleukin-6 (IL-6) was originally found as a cytokine in leukocytes that is involved in 
inflammation responses. With recent discovery of skeletal muscle endocrine function, several 
classical cytokines were found to be secreted from skeletal muscle, termed myokines. IL-6 has 
shown to be released from skeletal muscle as a myokine. As heterogenous tissue, skeletal muscle 
consists of at least four different types of muscle fibers characterized by distinct metabolic and 
functional properties. While IL-6 is known to regulate muscle metabolism and function, whether 
IL-6 release from skeletal muscle is muscle type specific is unclear. This study was designed (1) 
to validate an ex vivo method to test IL-6 release from isolated mouse skeletal muscle; and (2) to 
compare IL-6 release from slow and fast twitch muscle. Male and female C57/B6 mice at the 
ages of 3-4 months were anesthetized with isoflurane, extensor digitorum longus (EDL) (fast-
twitch muscle) and soleus (slow-twitch muscle) were isolated and incubated in Krebs solution at 
37 ºC with bubbling oxygen. Secreted IL-6 in the media was detected by the ELISA and western 
blot analyses. The results showed that IL-6 release was induced from isolated muscle in a 
temperature and O2 dependent manner. IL-6 muscle release was cell-type specific with little 
secretion shown from the EDL but a strong release from soleus. Consistently, IL-6 protein 
secretion was greater in soleus tissue than that in EDL tissue. Moreover, while EDL expresses 
and releases little IL-6, it shows strong release of MMP-9 and other unidentified proteins. 
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1.I. Skeletal muscle, a heterogenous organ, and its major fiber types 
Skeletal muscle is the most abundant tissue in the body that performs with skeletal movement as 
a primary function; Skeletal muscle tissue is heterogenous or tissues with different characteristics 
depending on the body’s needs (Schiaffino, 2011). Body’s functional needs include a spectrum 
from continuous low-intensity movements (posture, long-distance running), to fast, maximal 
contraction movements (sprinting, jumping). While muscle composition is widely caused by 
phenotypic and genotypic factors, the nervous system can play a role in determining muscle 
fiber-type when muscle fibers form together to create a muscle (Schiaffino, 2011).  In the human 
body, there are at least four types of muscle fibers, characterized by the distinct metabolism and 
function, type I, type IIa, type IIb, and type IIx. Studies show that different fiber-types have two 
different physiological types: speed of contraction and resistance to fatigue. Additionally, the 
different fiber-types show to have different enzymatic activity where type IIa and type IIb fibers 
have shown to have high levels of glycolytic enzymes (low levels of mitochondria, highly 
developed sarcoplasmic reticulum), and type-I fibers have shown evidence of fatty-acid 
oxidative enzymes which means high levels of mitochondria and lesser developed sarcoplasmic 
reticulum (Schiaffino, 2011).  Furthermore, studies have shown difference among type IIa and 
type IIb muscle fibers. Type IIa muscle fibers are fast-twitch, oxidative fibers that resist fatigue 
better than type-IIb fibers that are fast-twitch, glycolytic fibers that are quick to fatigue. These 
three fiber types are important when studying how the body moves with performance and 
efficiency. However, there is an additional type II, fast-twitch muscle fiber that was discovered 
known as type IIx which has similar glycolytic characteristics to type IIa and type IIb fibers but 
resists fatigue intermediate to them (Schiafino, 2011). Muscle-type distribution throughout the 
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body varies among species, sex, and heredity and a mix of the fiber types is helpful for efficient 
but powerful movement depending on the body’s necessities. When studying muscle physiology, 
it is important to look at different fiber-types to better understand the differences among them 
with regards to function and action.  
1.II. Skeletal muscle secretory function  
Recent studies show that muscles not only produce contractions that help with skeletal 
movement but also have secretory functionality to release myokines, cytokines that are secreted 
by muscle tissue (Pedersen and Fischer, 2007). Evidence points to muscular communication 
with other tissues throughout the body by secreting myokines into the blood stream. According 
to Pedersen et. al., myokines communicate with other tissues (i.e. endocrine and paracrine) as 
well as communicate within the muscle tissue (autocrine) to signal hypertrophy, myogenesis, or 
AMPK-mediated fat-oxidation. Examples of myokines include IL-6, brain derived neurotropic 
factor (BDNF) and IL-7, and there are many more that have exclusive endocrine functionality in 
the muscle tissue. There are also myokines that help with circulation such as IGF-1 and FGF-2 
which are just some examples. The overall effects of these myokines seem to be related to 
pancreas function and cancer growth (Pedersen, et al. 2009). Exercise induced release of 
these myokine may have protective characteristics to prevent diseases that are correlated with 
a lack of exercise.  
1.III. Interleukin-6 as a myokine  
Interleukin-6 is an interleukin which is a cytokine that was originally found to be secreted 
by white-blood cells and helps to regulate cell differentiation, growth, and activation during an 
immune response (Brocker, et al. 2010). Because of continuous evolution of white-blood cell 
DNA composition, it is difficult to classify interleukin cytokines; however, evidence suggests 
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that IL-6 assists with inflammation, cell-survivability, and cell-differentiation for leukocytes.  
Emerging evidence shows that IL-6 is also produced and secreted in a variety of non-immune 
tissues, including skeletal muscle. IL-6 myokine secretion is said to have anti-inflammatory 
function and its secretion is 100-fold during muscular exercise (Febbraio and Pedersen, 2005). 
Surfacing data is showing that skeletal muscle is a major influencer in metabolism by myokine 
secretion (Ling, et al. 2018). While IL-6 enhances insulin production during post-exercise, IL-6 
can also be linked to obesity and reduced insulin action (Febbraio and Pedersen, 2008). Studies 
show that muscle-derived IL-6 secretion during exercise could be a signal that glycogen levels 
are “critically low” and that blood glucose is the main source of fuel for the active skeletal 
muscles. 
 Skeletal muscle tissue is a major component of the body by encompassing over 40% of 
total body mass. The muscle endocrine functions are being widely studied as these myokines 
help to regulate muscular performance, metabolism, and myogenesis pathways. Not only does 
IL-6 play a role in glucose uptake by muscle cells, it will also stimulate a lipolysis pathway by 
phosphorylating AMPK (AMP-kinase) in fat cells (Febbraio and Pedersen, 2008). Not only 
could a greater understanding of IL-6 help understand its functional mechanisms, but it could 
also help clinicians when helping patients with metabolic disorders. Given the important role of 
muscle derived IL-6 in regulation of muscle performance and metabolism, it is surprising how 
little is known regarding IL-6 secretion in different muscle fiber types.  
In the present study, mouse soleus muscle, which primarily consists of slow oxidative 
(type I) fibers, and extender digitorum longus (EDL) muscle which mainly has fast glycolytic 




Fig.1 IL-6 release from skeletal muscle (Pedersen and Fischer, 2007) 
Figure one represents a diagram of the effects that IL-6 has on systems of the body. After 
skeletal-muscular contraction, IL-6 regulates multiple pathways such as increased glucose uptake 
in the muscle cells, increased glucose production in the liver, and increased lipolysis or fat-
oxidation in the adipose tissue. Not only will these pathways benefit the body’s performance as a 
whole, the body could see other benefits such as a decrease in body weight due to oxidation of 
adipose tissue and increased glucose use in muscle tissue. IL-6 is important to study now that 
scientists have proven that muscle tissue secretes this myokine because of its potential use in 
medical treatment for patients with metabolic disorders, muscle diseases, or other possible 
problems (Pedersen).  
 
 
 1.IV. Brain Derived Neurotrophic Factor released from skeletal muscles  
   BDNF is a growth factor in the nervous system that is associated with learning, 
memory, and neural plasticity (Pedersen et al. 2009). Recent evidence has shown BDNF as an 
important regulator of metabolism in peripheral tissue. Furthermore, BDNF has been shown to 
be released from the skeletal muscle tissue and is now considered a myokine as well. According 
to Pedersen et. al., BDNF was shown to be a cofactor for stimulation of AMPK, and acetyl 
coenzyme A and has been shown to increase fatty acid oxidation in vitro and in vivo. BDNF is 
another myokine that is being studied in Dr. Li’s laboratory.  In the present study, BDNF release 
from the soleus and EDL were also tested in comparison with IL-6.  
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The overall hypothesis of this study was that IL-6 and BDNF release may be different from 
slow and fast muscle fibers.      
  
2. Methods 
2.I.: Muscle isolation and ex vivo incubation:  
Adult male and female C57/ B6 mice were used at the ages of 3-4 months. The protocol 
for use of animals was reviewed and approved by USD IACUC and was in compliance with NIH 
guideline of use for animals in research. Isoflurane was used to anesthetize the mice, the skin of 
the hind limb was removed, and soleus and EDL were isolated, dissected from the body, and 
individually transferred to a Krebs solution containing bubbling oxygen.  
2.II. Induction/inhibition of IL-6 release  
Each sample of EDL or soleus muscle was incubated using 150 microliters of fresh Krebs 
solution in a tube. A stimulation cocktail (Thermo-Fisher Inc, # 00-4970-03), secretion transport 
inhibitor (# 00-4980-03), or the stimulation cocktail plus the inhibitor (# 00-4975-93) were added 
into the solution at 1:500 dilution. Equal volume of Krebs solution was added to the control 
sample. Each tube was incubated at 37º C with oxygen bubbling for one hour. One experiment 
tested the effect of temperature on IL-6 release, tubes were incubated at room temperature (~20º 
C) for one hour with oxygen supply. Another experiment tested of effect of oxygen on the release 
of IL-6 and tubes were incubated at 37º C for one hour without bubbling oxygen.  
2.III. Detection of release IL-6 in incubation media and muscles (Western blot and 
ELISA) 
After the one-hour incubation period, media and muscle tissue were collected. Protein 
levels of IL-6 or BDNF in the collected media were detected using ELISA kit (Biolegend, Inc.) 
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or Western blot using an antibody for IL-6 or BDNF (Santa Cruz Biotechnologies). The muscle 
tissues were homogenized in a RIPA buffer containing protease and phosphatase inhibitor 
cocktail (Thermo-Fisher, Inc.) After 10,000 X g centrifugation for 10 minutes, concentration of 
protein in the supernatant of homogenates was determined and then normalized. Proteins of 
interest, including IL-6 and BDNF, were determined using the standard western blot technique as 
described before using their respective antibodies (Liang, et al. 2018). 
2.IV. Immunofluorescence staining for IL-6 in muscle 
In order to detect IL-6 in the muscle fibers, we used immunofluorescent staining. Fresh 
muscle tissues that were dissected were frozen on dry-ice. After, the tissues were embedded with 
optimal cutting temperature compound (OCT, Sakura Finetek USA, Inc.) and sectioned at 10 
micrometer thickness using a cryostat (Leica). Next, the tissue was fixed in 4% formaldehyde for 
20 minutes and washed multiple times with PBST. The tissue sections were then blocked with 
1.5% BSA at room temperature for an hour and then incubated with primary antibody against IL-
6 (rabbit antibody, ProteinTech, Inc.) at 4º C overnight. After more washes, the sections were 
incubated with a secondary antibody against rabbit Ig conjugated with fluorescent dye. The final 
slide images were taken using a fluorescent microscope (Olympus).  
 
2.V Data analysis and statistics 
ELISA quantification of IL-6 in the media was presented as mean ± standard deviation. 
The statistical comparisons were performed using one-way ANOVA followed by post hoc 






3.I IL-6 was inducible from muscle in ex vivo condition
Fig. 2. Ex vivo incubation of isolated mouse soleus (darker) and EDL (lighter). Muscle tissues 
were isolated from mouse and placed into individual tubes with bubbling oxygen and Kreb’s 
solution. The metal piece behind the tubes is the incubation chamber that will keep the muscle 
samples at 37 ºC for one hour.  
  
 
Fig. 3. IL-6 was inducible in ex vivo incubation. A: Western blot (top) and ELISA quantification 
(bottom) of IL-6 in the media of control (C), treatment with cytokine release stimulant cocktail 
(S), treatment with the stimulant and a cytokine release inhibitor (S+I), and the inhibitor alone 
(I), ELISA assay, n=4. B: Western blot (top) and ELISA quantification (bottom) of IL-6 in the 
media; control (C), stimulant (S) with 37 ºC and oxygen supply conditions (left), 20 ºC with 




Figures 2 and 3 demonstrate a validation of the ex vivo approach for the measurement of 
IL-6 release from skeletal muscle. The isolated muscles were incubated at 37 ºC with constant 
oxygen supply and were either stimulated, not stimulated, or treated with a stimulant inhibitor. 
As shown in panel A of figure 3, little IL-6 was secreted in control conditions, but a strong IL-6 
release was induced by the stimulant, which was abolished by the secretion inhibitor. These 
results are consistent for the western blot and ELISA analyses. These results suggest that the IL-
6 release was inducible and there was not spontaneous leak. The purpose of this experiment was 
to confirm that the ex vivo approach for IL-6 muscle secretion study was functional.  
To further demonstrate that the ex vivo method was a physiological release, we tested 
different physiological conditions to compare release of IL-6. Detailed in panel B of figure 3, IL-
6 release was studied with changes to temperature or changes to oxygen supply. Under normal 
physiological conditions (37 ºC + oxygen), the stimulated muscle tissue released a significant 
amount of IL-6. When the muscle was incubated in 20 ºC with oxygen, there was minimal 
release of IL-6 in the stimulated muscle, similar to the control muscle in these conditions. This 
shows the importance of physiological temperature for optimal release of IL-6. Additionally, 
when the muscle tissue was at physiological temperature but was incubated without oxygen, 
there was significant release in both control and stimulated muscle. These studies demonstrate 
the importance of physiological conditions for proper release of IL-6 and shows that an ex vivo 
study is a viable method to measure release of IL-6 in skeletal muscles.  
3.II IL-6 was inducible from soleus but not EDL 
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Fig 4. IL-6 was inducible from soleus but not from EDL muscle. A: Western blot (top) and 
ELISA quantification (bottom) of IL-6 release into the media from the soleus or EDL muscles, 
control (C) or treatment with cytokine release stimulant cocktail (S), ELISA assay, n=4.  B: 
Western blot (top) and ELISA quantification (bottom) of IL-6 release into the media from the 
soleus or EDL muscles, control (C) or treatment with nicotine (Nic), ELISA assay, n=4. Nicotine 
was used to stimulate the nicotine-cholinergic receptor on the muscle to compare with the 
stimulation cocktail used in panel A.  
 
Using the ex vivo method that we demonstrated to be viable in 4.I, we compared IL-6 
release from the soleus, a slow twitch muscle, and EDL, a fast twitch muscle. Isolated muscle 
samples were incubated for one hour as a control or with the stimulation cocktail. While the 
stimulation cocktail was able to induce a substantial amount of IL-6 in the soleus, there was no 
induction of IL-6 release in the EDL. This finding suggests that IL-6 myokine release is muscle 
type specific and not arbitrary.  
 Furthermore, to test if the EDL and soleus muscles could be induced for IL-6 release by 
other stimulants, we stimulated the incubated muscles with nicotine (1 µM) which is an agonist 
for nicotinic cholinergic receptors on a neuromuscular junction. Similar to the stimulation 
37ºC+O2 37ºC+O2 
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cocktail, nicotine was able to induce IL-6 release from the soleus but not from the EDL which 
adds further evidence for muscle type specific release of IL-6.  
3.III IL-6 protein level was different in soleus and EDL tissues 
 
Fig 5. IL-6 protein level in muscle tissues. A: Western blot image (top) and quantification 
(bottom) of IL-6 and GAPDH protein levels in soleus (black bar) and EDL (grey bar). B: 
immunofluorescence staining of IL-6 in gastrocnemius muscle showing stronger signal in 
the oxidative fibers (smaller fibers). C: Western blot image (top) and quantification 
(bottom) of IL-6 receptor alpha and GAPDH in soleus (black bar) and EDL (grey bar).  
  
Our next test was to see if IL-6 protein concentration within the muscle tissue is different 
between the two muscle types. Western blot analysis between the soleus and EDL muscle tissue 
was performed which showed significantly more IL-6 protein in the soleus tissue when 
compared to the EDL tissue. Also, immunofluorescent staining of the gastrocnemius muscle, 
which contains oxidative slow-twitch muscle fibers and glycolytic fast-twitch muscle fibers, , 
showed a good IL-6 signal in the slower oxidative fibers (smaller size) compared to the faster 
glycolytic fibers (larger size), which indicates IL-6 is expressed in greater amounts in the slower 
oxidative muscle fibers. Protein level of IL-6 receptors (IL-6Ra) was comparable between the 
two muscles. Future immunofluorescence staining will be done on EDL and soleus to see IL-6 
signaling in different muscle types.   
      Soleus    EDL  
37ºC+O2 37ºC+O2 
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Fig 6. BDNF released from soleus and EDL. Western blot analysis (top) of muscle incubation 
media (incubated for one hour). Pro-BDNF and mature BDNF were induced to release from the 
soleus but EDL was not inducible. ELISA quantification (bottom) for BDNF in muscle 
incubation media with or without stimulation, ELISA assay, n=4.  
 
 BDNF showed similar results to the IL-6 myokine as they both were inducible 
from the soleus but not from the EDL. Using the same viable method as the IL-6 experiment, we 
stimulated the soleus and EDL under physiological conditions. The Western blot and ELISA 
analysis demonstrated that soleus secreted a significant amount of BDNF, but the stimulated 
EDL release a little BDNF, similar to the control.  
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3.V Soleus and EDL have different secretome (secretory function) 
 
Fig. 7 Soleus and EDL have different secretome. A: gel Coomassie staining of proteins in the 
media of soleus and EDL with control or stimulated muscles. The white arrows indicate bands 
that are secreted from soleus and the black arrow indicates a band secreted from EDL. B: 
western blot images of MMP9, MKP-1, BDNF, and IL-6 in incubation media of soleus or EDL 
of control (C) or stimulation (S).  
 
A question that was raised from the lack of IL-6 release and BDNF release in the EDL 
muscle was if EDL muscle had secretory function at all. We compared the total amount of 
proteins in the media of the soleus and EDL before and after stimulation. According to the gel 
Coomassie staining, the stimulation increased total secreted proteins in both the soleus and EDL 
muscles. Additionally, there were some protein bands that were different in the EDL compared 
to the soleus which suggests that EDL still has secretory function but with different secretome 
profile from that of soleus. This suggests that the secretome is different between the two muscles 
but that they both respond to the same stimulation. As an exmple, in western blot, IL-6 and 
37ºC+O2 37ºC+O2 
 19 
BDNF were only secreted from the soleus, not from EDL. However, MMP-9 was secreted with 
greater amount from the EDL than the soleus.  MKP-1 was secreted similarly between the soleus 
and EDL. This data suggests that glycolytic and oxidative muscle fiber types have secretory 
function but the secretome is different between the two.  
 
4. Discussion 
IL-6 secretion from skeletal muscle was suggested to increase during exercise which was 
confirmed by study of primary muscle cells (Pedersen and Fischer, 2007). While skeletal 
muscle is a heterogeneous tissue with different metabolic and contractile characteristics, it is 
unknown if IL-6 release is muscle type specific. With current in vitro and in vivo technologies, it 
is difficult to study IL-6 release. Our ex vivo model was effective when studying muscle 
secretion in different muscle types. A critical question that must be addressed is whether the 
myokine release from the isolated muscle is functional secretion or spontaneous leak.  Our data 
show that the ex vivo IL-6 release was dependent on physiological conditions and blocked by an 
inhibitor, which gives evidence that the ex vivo IL-6 release was physiological and not 
spontaneous leak. Slow, oxidative tissues released IL-6 at 37 ºC with bubbling oxygen supply in 
Krebs solution and stimulation cocktail while fast, glycolytic tissues did not induce release of IL-
6 under the same conditions. Under similar conditions but with 20 ºC incubation, IL-6 was not 
released from soleus or EDL which demonstrates more evidence for this effective model. Our 
effective model showed the necessity for appropriate physiological temperature, constant oxygen 
supply, and undamaged muscle tissue. Furthermore, this approach can be used to study different 
myokines under different types of stimulants like nicotine.  
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Using this effective model, we studied the difference in IL-6 release in the soleus and 
EDL muscles. EDL is a good example of a fast, glycolytic muscle, and soleus is a good example 
of a slow, oxidative muscle, and these two muscles were extracted from anesthetized mice of 
ages 3-4 months. These two muscles are good to study as they are easy to be isolated, and they 
are similar in size. Our evidence demonstrated that IL-6 was only inducible from the stimulated 
soleus muscle and not from the EDL. Furthermore, immunofluorescence of the gastrocnemius 
muscle, a mix of glycolytic and oxidative fibers, showed that IL-6 signal was higher in the 
smaller oxidative fibers as compared to the bigger glycolytic fibers that showed little to no signal 
for IL-6. We also tried comparing the normal cytokine stimulation cocktail with nicotine, a 
nicotine cholinergic stimulant for the neuromuscular junction, and these both showed similar 
results for the release of IL-6 from the soleus but not EDL. Still unknown to the experiment is if 
glycolytic fibers can release IL-6 under different metabolic conditions or stimuli. A possible test 
for this response would be to incubate glycolytic muscle with insulin in order to see the different 
response for glucose/glycolysis levels in the muscle which may help with release of IL-6 in the 
fast muscle. This knowledge would be beneficial for the study of IL-6 role in metabolism and 
how it is regulated in the skeletal muscle for different fiber types.  
An important precursor to these experiments was to prove that glycolytic muscle fibers 
can still have myokine secretory function. We found that the total proteins released from the 
EDL was comparable to the soleus and both increased during stimulation. This demonstrates that 
EDL still has secretory function when stimulated, but that the response may be different than in 
the soleus. Furthermore, the Coomassie gel showed that EDL and soleus had different protein 
banding under stimulation which shows different responses to stimulation. After further study 
with different antibodies in the western blot analysis, soleus was shown to release BDNF and IL-
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6 while EDL released MMP-9 more than soleus. MKP-1 release was similar between the two 
muscle types. Slow fibers and fast fibers have similar response to stimulation, but the proteins 
released are different. This phenomenon is potentially important as in the clinic there could be 
metabolic deficiencies linked with BDNF and IL-6 that could be better treatable with better 
understanding of these myokines. The ex vivo model will be helpful in further studying myokine 
release and its function within the skeletal muscle tissue.  
In summary, this study validated an ex vivo method for study of myokine release from 
isolated muscle. The experiments using this method identified that IL-6 and BDNF were 
specifically released from slow oxidative muscle but not fast glycolytic muscle. This method and 
information are important for the future study of regulation and function of myokine secretion.   
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